H14 S.p.A. has acquired a minority stake in the Saint Camillus International University of Health and Medical Science in Rome, with plans to enhance its educational capabilities and expand international collaborations.

Target Information

H14 S.p.A., a family office owned by Barbara, Eleonora, and Luigi Berlusconi, has successfully acquired a minority stake in the Saint Camillus International University of Health and Medical Science, located in Rome. This private university, founded in 2018 by Gianni Profita, serves as a premier institution for medical and healthcare education in Italy. Originally established as a traditional university, it has transitioned into a phase of progressive digitalization and growth, solidifying its status as a leader in training professionals in the medical and healthcare sectors.

The investment from H14 is expected to enhance the university's presence across Italy and facilitate the expansion of international collaborations. Furthermore, it aims to support investments in state-of-the-art infrastructure and technology, as well as to improve the institution's human capital.

Industry Overview

The education sector in Italy, particularly in the field of healthcare and medical sciences, has been experiencing a significant transformation propelled by digitalization and evolving market demands. The private education market ha

View Source

Similar Deals

AMF Group Benelli Ademaro

2025

Other Private Equity Luxury Accessories Italy
Pollen Street Public Sector Entities receivables portfolio

2025

Other Private Equity Government & Government Finance (NEC) Italy
Vertigo Capital Via Tuscolana

2025

Other Private Equity Residential Real Estate Rental & Development Italy
De Agostini Legami S.p.A.

2025

Other Private Equity Office Supplies & Stationery Stores Italy
FSI Casalasco S.p.A.

2025

Other Private Equity Fruit & Vegetable Processing Italy
CDP Venture Capital Nova

2025

Series A Professional & Business Education Italy

H14 S.p.A.

invested in

Saint Camillus International University of Health and Medical Science

in 2025

in a Other Private Equity deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert